NO20013337L - New treatment - Google Patents
New treatmentInfo
- Publication number
- NO20013337L NO20013337L NO20013337A NO20013337A NO20013337L NO 20013337 L NO20013337 L NO 20013337L NO 20013337 A NO20013337 A NO 20013337A NO 20013337 A NO20013337 A NO 20013337A NO 20013337 L NO20013337 L NO 20013337L
- Authority
- NO
- Norway
- Prior art keywords
- new treatment
- treatment
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9900630 | 1999-01-12 | ||
PCT/EP1999/010295 WO2000041463A2 (en) | 1999-01-12 | 1999-12-21 | Combination of hepatitis b vaccine with antiviral agents |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20013337D0 NO20013337D0 (en) | 2001-07-05 |
NO20013337L true NO20013337L (en) | 2001-08-17 |
Family
ID=10845878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20013337A NO20013337L (en) | 1999-01-12 | 2001-07-05 | New treatment |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1140163A2 (en) |
JP (1) | JP2002534438A (en) |
KR (1) | KR20010090011A (en) |
CN (1) | CN1391482A (en) |
AR (1) | AR022250A1 (en) |
AU (1) | AU760574B2 (en) |
BR (1) | BR9916893A (en) |
CA (1) | CA2359110A1 (en) |
CO (1) | CO5241355A1 (en) |
CZ (1) | CZ20012544A3 (en) |
HK (1) | HK1041434A1 (en) |
HU (1) | HUP0105070A2 (en) |
IL (1) | IL144186A0 (en) |
NO (1) | NO20013337L (en) |
NZ (1) | NZ512890A (en) |
PL (1) | PL349347A1 (en) |
TR (1) | TR200102024T2 (en) |
WO (1) | WO2000041463A2 (en) |
ZA (1) | ZA200105690B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU761899B2 (en) | 1998-05-22 | 2003-06-12 | Ottawa Health Research Institute | Methods and products for inducing mucosal immunity |
BRPI9912663B8 (en) | 1998-07-31 | 2021-07-06 | Int Inst Cancer Immunology Inc | vaccine against cancer and polypeptide. |
ES2298353T3 (en) | 2001-03-22 | 2008-05-16 | International Institute Of Cancer Immunology, Inc. | MODIFIED WT1 PEPTIDE. |
JPWO2003028758A1 (en) * | 2001-09-28 | 2005-01-13 | 治夫 杉山 | Method for inducing antigen-specific T cells |
EP1447091A4 (en) | 2001-09-28 | 2008-02-13 | Institute Of Can International | Novel method of inducing antigen-specific t cells |
MY131488A (en) * | 2002-04-08 | 2007-08-30 | Bristol Myers Squibb Co | Low dose liquid entecavir formulations and use |
MXPA05004588A (en) | 2002-10-29 | 2005-12-14 | Coley Pharmaceutical Group Ltd | Use of cpg oligonucleotides in the treatment of hepatitis c virus infection. |
EP1578954A4 (en) | 2002-12-11 | 2010-08-11 | Coley Pharm Group Inc | 5' cpg nucleic acids and methods of use |
CN100443117C (en) * | 2003-05-13 | 2008-12-17 | 深圳康泰生物制品股份有限公司 | Hepatitis B treating vaccine prepn and its prepn process and use |
US8541167B2 (en) | 2004-06-03 | 2013-09-24 | Saint Louis University | Methods and compositions for vaccination |
AR065504A1 (en) * | 2007-02-28 | 2009-06-10 | Ct Ingenieria Genetica Biotech | COMBINED THERAPY FOR THE TREATMENT OF CHRONIC HEPATITIS B. USE. |
EP3903815A4 (en) * | 2018-12-24 | 2022-09-28 | Grand Theravac Life Science (Nanjing) Co., Ltd. | Pharmaceutical preparation for treating hepatitis b, preparation method therefor and use thereof |
US20240207395A1 (en) * | 2021-04-07 | 2024-06-27 | Denka Company Limited | Adjuvant activity enhancer and adjuvant composition |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0414374T3 (en) * | 1989-07-25 | 1998-03-09 | Smithkline Beecham Biolog | New antigens and methods for their preparation |
HUP0101047A3 (en) * | 1998-03-09 | 2004-10-28 | Smithkline Beecham Biolog | Combined vaccine compositions |
-
1999
- 1999-12-21 WO PCT/EP1999/010295 patent/WO2000041463A2/en not_active Application Discontinuation
- 1999-12-21 PL PL99349347A patent/PL349347A1/en not_active Application Discontinuation
- 1999-12-21 KR KR1020017008833A patent/KR20010090011A/en not_active Application Discontinuation
- 1999-12-21 JP JP2000593088A patent/JP2002534438A/en active Pending
- 1999-12-21 BR BR9916893-6A patent/BR9916893A/en not_active IP Right Cessation
- 1999-12-21 IL IL14418699A patent/IL144186A0/en unknown
- 1999-12-21 HU HU0105070A patent/HUP0105070A2/en unknown
- 1999-12-21 CA CA002359110A patent/CA2359110A1/en not_active Abandoned
- 1999-12-21 CN CN99816471A patent/CN1391482A/en active Pending
- 1999-12-21 AU AU21009/00A patent/AU760574B2/en not_active Ceased
- 1999-12-21 TR TR2001/02024T patent/TR200102024T2/en unknown
- 1999-12-21 CZ CZ20012544A patent/CZ20012544A3/en unknown
- 1999-12-21 EP EP99965531A patent/EP1140163A2/en not_active Withdrawn
- 1999-12-21 NZ NZ512890A patent/NZ512890A/en unknown
-
2000
- 2000-01-11 AR ARP000100107A patent/AR022250A1/en not_active Application Discontinuation
- 2000-01-12 CO CO00001261A patent/CO5241355A1/en not_active Application Discontinuation
-
2001
- 2001-07-05 NO NO20013337A patent/NO20013337L/en not_active Application Discontinuation
- 2001-07-11 ZA ZA200105690A patent/ZA200105690B/en unknown
-
2002
- 2002-02-19 HK HK02101211.9A patent/HK1041434A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU760574B2 (en) | 2003-05-15 |
BR9916893A (en) | 2001-11-20 |
EP1140163A2 (en) | 2001-10-10 |
AU2100900A (en) | 2000-08-01 |
CA2359110A1 (en) | 2000-07-20 |
KR20010090011A (en) | 2001-10-17 |
HK1041434A1 (en) | 2002-07-12 |
JP2002534438A (en) | 2002-10-15 |
NO20013337D0 (en) | 2001-07-05 |
WO2000041463A2 (en) | 2000-07-20 |
CZ20012544A3 (en) | 2002-01-16 |
TR200102024T2 (en) | 2001-12-21 |
PL349347A1 (en) | 2002-07-15 |
AR022250A1 (en) | 2002-09-04 |
CN1391482A (en) | 2003-01-15 |
ZA200105690B (en) | 2002-09-25 |
NZ512890A (en) | 2003-09-26 |
WO2000041463A3 (en) | 2000-11-09 |
IL144186A0 (en) | 2002-05-23 |
HUP0105070A2 (en) | 2002-04-29 |
CO5241355A1 (en) | 2003-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20001870D0 (en) | New procedure for treatment | |
DE69924365D1 (en) | MASSAGER | |
DK1637127T3 (en) | THERAPEUTIC MICROSUM | |
ID26056A (en) | DIAPON ONCE USE | |
NO2010019I2 (en) | 6-per-deoxy-6-per- (2-karboksetyl) thio-y-cyclodextrin | |
ID26389A (en) | DIAPON ONCE USE | |
NO20014490D0 (en) | Medical mixtures | |
NO20032122D0 (en) | Improved treatment | |
NO20005179D0 (en) | Drug treatment | |
DE60023454D1 (en) | LAGENMATERIALEN TENSID-MODIFIED CHELATBILDERN TREATED | |
DE60017816D1 (en) | Pacemaker | |
ATE269391T1 (en) | LAUNDRY TREATMENT | |
ID24782A (en) | DIAPON ONCE USE | |
ID25571A (en) | DIAPON ONCE USE | |
NO20013337L (en) | New treatment | |
DE60016600D1 (en) | PACEMAKER | |
DE59911113D1 (en) | PACEMAKER | |
DE69916133D1 (en) | ELECTRO-NEURO-ADAPTIVE STIMULATOR | |
DE60023003D1 (en) | HAIR TREATMENT AGENT | |
DE60013608D1 (en) | PACEMAKER | |
ATE290060T1 (en) | LAUNDRY TREATMENT | |
DE60016452D1 (en) | PACEMAKER | |
NO20012301D0 (en) | New procedure for treatment | |
ATA203199A (en) | PROCEDURE | |
DK1043026T3 (en) | melanoma treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |